Literature DB >> 1218822

Serum lysozyme in inflammatory bowel disease.

M W Dronfield, M J Langman.   

Abstract

The mean concentrations of serum lysozyme were markedly higher in patients with Crohn's disease and ulcerative colitis than in normal controls, and mean levels tended to be slightly higher in those with Crohn's disease than in those with colitis. The significance of these differences is unclear but the overlap between values in normal individuals and those with inflammatory bowel disease prevents the measurement having any discriminant value.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1218822      PMCID: PMC1413167          DOI: 10.1136/gut.16.12.985

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  The distribution of muramidase (lysozyme) in human tissues.

Authors:  D Y Mason; C R Taylor
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

2.  Serum lysozyme in Crohn's disease and ulcerative colitis.

Authors:  K R Falchuk; J L Perrotto; K J Isselbacher
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

3.  Studies of lysozyme in ulcerative colitis.

Authors:  S J GRAY; R W REIFENSTEIN; E P CONNOLLY; H M SPIRO; J C G YOUNG
Journal:  Gastroenterology       Date:  1950-12       Impact factor: 22.682

4.  Serum lysozyme in pulmonary tuberculosis.

Authors:  P E Perillie; K Khan; S C Finch
Journal:  Am J Med Sci       Date:  1973-04       Impact factor: 2.378

5.  Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis.

Authors:  R S Pascual; J B Gee; S C Finch
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

6.  Serum muramidase and granulocyte turnover.

Authors:  M E Fink; S C Finch
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

7.  Lysozyme turnover in man.

Authors:  N E Hansen; H Karle; V Andersen; K Olgaard
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

8.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

  8 in total
  6 in total

1.  Circulating human leucocyte elastase in patients with inflammatory bowel disease.

Authors:  E O Adeyemi; S Neumann; V S Chadwick; H J Hodgson; M B Pepys
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

2.  Serum lysozyme levels in malignant histiocytosis of the intestine.

Authors:  J R Hodges; P Isaacson; O E Eade; R Wright
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

3.  Complex nature of serum lysozyme activity: evidence of thermolability in inflammatory bowel disease.

Authors:  M Ward; W D Mitchell; M Eastwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

4.  Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.

Authors:  W Pruzanski; N Marcon; C Ottaway; E Prokipchuk
Journal:  Am J Dig Dis       Date:  1977-11

5.  Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.

Authors:  M Klockars; S Reitamo; J J Reitamo; C Möller
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

6.  Serum and faecal lysozyme in inflammatory bowel disease.

Authors:  H J Klass; G Neale
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.